Measuring metabolites in melanoma patients using advanced techniques
Measurement of the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography.
This study is testing if analyzing blood and other body fluids from melanoma patients can help spot the disease earlier and track any changes in their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Technische Universität Dresden Academic / other |
| Locations | 1 site (Dresden, Saxony) |
| Trial ID | NCT06765850 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the metabolome of blood samples and other body fluids from melanoma patients at various stages of the disease, as well as from healthy individuals. By employing NMR spectroscopy and gas chromatography, the study seeks to identify metabolic differences that could aid in the early detection of melanoma, recurrence, or changes in disease stage. The biosamples will be collected at the BioBank Dresden and may be used for additional analyses in the future.
Who should consider this trial
Good fit: Ideal candidates include individuals with a current or past history of melanoma who are receiving treatment or follow-up care at the Skin Cancer Centre at Dresden University Hospital.
Not a fit: Patients who refuse to participate or lack the capacity to consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and monitoring of melanoma, enhancing patient outcomes.
How similar studies have performed: While the approach of using metabolomics for cancer detection is gaining traction, this specific study's methodology is relatively novel and has not been extensively tested in melanoma.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current or past history of melanoma * Ongoing therapy or tumour aftercare at the Skin Cancer Centre at Dresden University Hospital Exclusion Criteria: * Refusal to participate in the study * Lack of capacity to consent
Where this trial is running
Dresden, Saxony
- University Hospital Carl Gustav Carus — Dresden, Saxony, Germany (Recruiting)
Study contacts
- Study coordinator: Frank Friedrich Gellrich, Dr. med.
- Email: frankfriedrich.gellrich@ukdd.de
- Phone: +493514582497
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.